Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis"

Letter/Communication

Open access

Peer reviewed

Circulation (New York, N.Y.), Vol.130(22), pp.e194-e194

25/11/2014

Handle:

https://hdl.handle.net/10523/37562

Abstract

Atrial Fibrillation - drug therapy

Atrial Fibrillation - physiopathology

Benzimidazoles - adverse effects

Benzimidazoles - therapeutic use

beta-Alanine - analogs & derivatives

Female

Humans

Kidney - physiology

Male

Warfarin - adverse effects

Warfarin - therapeutic use

url

https://doi.org/10.1161/CIRCULATIONAHA.114.010099View

Published (Version of record) Open

8 Record Views

Record Identifier: 9926530254201891
Title: Letter by Chin et al regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis"
Creators: Paul K L Chin
Daniel F B Wright
Christopher M Florkowski
Publication Details: Circulation (New York, N.Y.), Vol.130(22), pp.e194-e194
Academic Unit: Pathology and Molecular Medicine (UOC); Medicine (UOC)
Date published ; e-published: 25/11/2014
Language: English
Resource Type ; Subtype: Letter/Communication